PHTF2 regulates lipids metabolism in gastric cancer
- PMID: 32335542
- PMCID: PMC7202541
- DOI: 10.18632/aging.102995
PHTF2 regulates lipids metabolism in gastric cancer
Retraction in
-
Retraction of: PHTF2 regulates lipids metabolism in gastric cancer.Aging (Albany NY). 2024 Apr 30;16(8):7507. doi: 10.18632/aging.205842. Epub 2024 Apr 30. Aging (Albany NY). 2024. PMID: 38688693 Free PMC article. No abstract available.
Abstract
Identification of hub genes and key pathways of gastric cancer was recognized to be essential to elucidate the tumorigenesis of GC. This study was aimed to identify the differentially expressed genes (DEGs) in GC via bioinformatics methods and their related pathways involved in the pathological process of GC. Gene expression profile datasets acquired by microarray chips or RNA-seq were downloaded from GEO dataset and TCGA, and 298 differentially expressed genes was identified. The Gene Ontology (GO) and Kyoto Gene and Genomic Encyclopedia (KEGG) pathways of DEGs were then analyzed by the DAVID database to elucidate the potential molecular functions of DEGs. The protein-protein interaction (PPI) network of DEGs was further analyzed with the STRING database and PHTF2 was identified as a hub gene in the PPI network. Subsequently, PHTF2 was found to be highly expressed in different subtypes of gastric cancer tissues obtained from TCGA database or clinical patients, resulting with a poor prognosis. By GSEA, PHTF2 was found to significantly enrich the fatty acid metabolism pathway in gastric cancer. Moreover, PHTF2-regulated lipids metabolism significantly affected the tumorigenesis of GC cells. In summary, this work identified a new mechanism by which PHTF2 precipitated in the pathological process of GC by regulating cellular lipid metabolism.
Keywords: PHTF2; gastric cancer; lipids metabolism; tumorigenesis.
Conflict of interest statement
Figures
Similar articles
-
Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.Int J Med Sci. 2021 Jan 1;18(3):792-800. doi: 10.7150/ijms.47339. eCollection 2021. Int J Med Sci. 2021. PMID: 33437215 Free PMC article.
-
Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.Med Sci Monit. 2021 Feb 14;27:e929104. doi: 10.12659/MSM.929104. Med Sci Monit. 2021. PMID: 33582701 Free PMC article.
-
Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.Med Oncol. 2020 Mar 27;37(5):34. doi: 10.1007/s12032-020-01362-0. Med Oncol. 2020. PMID: 32219571
-
Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.Pathol Res Pract. 2019 May;215(5):1038-1048. doi: 10.1016/j.prp.2019.02.012. Epub 2019 Feb 28. Pathol Res Pract. 2019. PMID: 30975489
-
Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer.Biomed Res Int. 2020 Aug 22;2020:2862701. doi: 10.1155/2020/2862701. eCollection 2020. Biomed Res Int. 2020. PMID: 32908877 Free PMC article.
Cited by
-
Key genes and molecular mechanisms related to Paclitaxel Resistance.Cancer Cell Int. 2024 Jul 13;24(1):244. doi: 10.1186/s12935-024-03415-0. Cancer Cell Int. 2024. PMID: 39003454 Free PMC article. Review.
-
Identification and validation of anoikis-associated gene SNCG as a prognostic biomarker in gastric cancer.Aging (Albany NY). 2023 Mar 30;15(7):2541-2553. doi: 10.18632/aging.204626. Epub 2023 Mar 30. Aging (Albany NY). 2023. PMID: 36996495 Free PMC article.
-
Differential co-expression network analysis elucidated genes associated with sensitivity to farnesyltransferase inhibitor and prognosis of acute myeloid leukemia.Cancer Med. 2023 Dec;12(24):22420-22436. doi: 10.1002/cam4.6804. Epub 2023 Dec 8. Cancer Med. 2023. PMID: 38069522 Free PMC article.
-
Molecular characterization of metabolic subtypes of gastric cancer based on metabolism-related lncRNA.Sci Rep. 2021 Nov 2;11(1):21491. doi: 10.1038/s41598-021-00410-7. Sci Rep. 2021. PMID: 34728653 Free PMC article.
-
APOA1 mRNA and serum APOA1 protein as diagnostic and prognostic biomarkers in gastric cancer.Transl Cancer Res. 2024 May 31;13(5):2141-2154. doi: 10.21037/tcr-23-1966. Epub 2024 May 23. Transl Cancer Res. 2024. PMID: 38881912 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
